Spore.Bio
Series AParis, FranceFeb 2025
Spore.Bio raised €22M in a Series A round in Feb 2025. The company is based in Paris, France. Investors in the round: 1st Kind Ventures, Famille C Venture, LocalGlobe and 4 others. Data as of 4 Nov 2026.
Amount raised
€22M
€22,024,323
Native amount
23,000,000 USD
Stage
Series A
series a
Investors
7
Provenance & confidence
High confidenceAmount
23,000,000 USD
ECB-at-date → €22M · rate 1.0443 on 2025-02-20
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
7 named1st Kind VenturesFamille C VentureLocalGlobeLord David PriorNo Label VenturesPoint72 VenturesSTATION F
Date
Feb 2025
Round type
series a
Amount (EUR)
€22M